
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Brepocitinib for noninfectious uveitis meets all phase 3 trial end points
2
BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial
3
FDA approves Brytly eye drops for ocular redness relief lasting up to 12 hours
4
More than monitoring: Using AMD visits to promote healthy vision aging
5











